Fda Approves Tembexa To Fight Weaponized Smallpox Virus Amid Fears Of Covid Lab Origins
Though the disease has been eliminated, the variola virus is still being kept in two labs—one in Atlanta and the other in Russia. The U.S. Food and Drug Administration (FDA) on Friday approved the drug Tembexa to treat smallpox, which is a contagious disease that’s sometimes fatal. Concerns of the variola virus have become even more heightened with fears of the COVID-19 coronavirus originated from a science lab. “Although naturally occurring smallpox no longer exists, concerns about potential uses of variola virus as a bioweapon has made smallpox drug development an important component of the U....